Journal of Adolescent Health
Volume 32, Issue 1 , Pages 89-93, January 2003

Pituitary apoplexy after leuprolide injection for ovum donation

  • Gregory Engel, M.D.

      Affiliations

    • Corresponding Author InformationAddress correspondence to: Gregory Engel, M.D., Stanford University School of Medicine, Falk Bldg., CVRC, 300 Pasteur Drive, Stanford, CA 94305
    • Department of Internal Medicine, Stanford University School of Medicine, Stanford, California, USA (G.E., C.A.C.)
    • ,
  • Michelle Huston, M.D.

      Affiliations

    • Department of Emergency Medicine, Stanford University School of Medicine, Stanford, California, USA (M.H., S.O.)
    • ,
  • Sachie Oshima, M.D.

      Affiliations

    • Department of Emergency Medicine, Stanford University School of Medicine, Stanford, California, USA (M.H., S.O.)
    • ,
  • Carter Beck, M.D.

      Affiliations

    • Department of Neurosurgery, Stanford University School of Medicine, Stanford, California, USA (C.B., G.H.)
    • ,
  • Griffith Harsh, M.D.

      Affiliations

    • Department of Neurosurgery, Stanford University School of Medicine, Stanford, California, USA (C.B., G.H.)
    • ,
  • Myer H Rosenthal, M.D.

      Affiliations

    • Department of Anesthesiology Stanford University School of Medicine, Stanford, CA, USA (M.H.R.)
    • ,
  • Carlos A Camargo, M.D.

      Affiliations

    • Department of Internal Medicine, Stanford University School of Medicine, Stanford, California, USA (G.E., C.A.C.)

Accepted 7 January 2002.

Abstract 

Abstract

Patients with occult pituitary adenomas infrequently present with pituitary apoplexy. Precipitation of pituitary apoplexy by gonadotropin releasing hormone or gonadotropin releasing hormone agonists has been described. The pathophysiologic mechanism by which these agents induce apoplexy remains unclear. We describe a case of pituitary apoplexy in a young woman receiving leuprolide in preparation for ovum donation. Severe hyponatremia, cerebral vasospasm and infarction, and diabetes insipidus complicated this patient’s prolonged hospital course. To our knowledge, pituitary apoplexy after gonadotropin releasing hormone agonist use for ovum donation has not been previously described. The use of leuprolide or other gonadotropin releasing hormone agonists for pituitary down-regulation in conjunction with ovarian stimulation can have serious consequences in women harboring unrecognized pituitary adenomas. Thorough endocrine screening should be performed prior to initiating therapy.

Keywords: Adolescents

 

PII: S1054-139X(02)00372-5

Journal of Adolescent Health
Volume 32, Issue 1 , Pages 89-93, January 2003

Article Tools

* Image Usage & Resolution